Showing results (71-80 of 131) with videos related to

Sort By:
Pageof 14
The European Respiratory Journal|August 31, 2013
EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotypeArne Warth, Roland Penzel, Heike Lindenmaier, et al.
Cancers|March 10, 2022
STAT1 and STAT3 Exhibit a Crosstalk and Are Associated with Increased Inflammation in Hepatocellular CarcinomaCarolin Ploeger, Johannes Schreck, Thorben Huth, et al.
Cancers|September 9, 2020
RNA Sequencing of Hepatobiliary Cancer Cell Lines: Data and Applications to Mutational and Transcriptomic ProfilingDominique Scherer, Marcela Dávila Dávila López, Benjamin Goeppert, et al.
BMC Cancer|January 17, 2019
Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma - correlation with clinicopathological data and comparison of antibodiesMark Kriegsmann, Stephanie Roessler, Katharina Kriegsmann, et al.
Cancers|January 21, 2022
HELLS Is Negatively Regulated by Wild-Type P53 in Liver Cancer by a Mechanism Involving P21 and FOXM1Stefanie Schuller, Jan Sieker, Philip Riemenschneider, et al.
Plos One|March 21, 2014
Netrin-1 expression is an independent prognostic factor for poor patient survival in brain metastasesPatrick N Harter, Jenny Zinke, Alexander Scholz, et al.
Cancers|July 2, 2021
Whole Exome Sequencing of Biliary Tubulopapillary Neoplasms Reveals Common Mutations in Chromatin Remodeling GenesClaudia Gross, Thomas Engleitner, Sebastian Lange, et al.
British Journal of Cancer|November 1, 2018
Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinomaBenjamin Goeppert, Stephanie Roessler, Marcus Renner, et al.
Hepatology (Baltimore, Md.)|January 8, 2019
Integrative Analysis Defines Distinct Prognostic Subgroups of Intrahepatic CholangiocarcinomaBenjamin Goeppert, Reka Toth, Stephan Singer, et al.
Neuro-Oncology|December 3, 2015
Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1, -2, and -3 and co-receptors neuropilin-1 and -2 does not predict bevacizumab response in human astrocytomasPeter Baumgarten, Anna-Eva Blank, Kea Franz, et al.
Pageof 14